Valuation Zenotech Laboratories Limited

Stocks

Delayed Bombay S.E. 02:01:45 2026-08-21 EDT			5-day change	1st Jan Change
45.65 ^INR	-0.35%		+4.70%	-1.08%

07-28	Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
04-29	Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	897.1	2,136	3,073	2,872	3,608	3,169
Change	-	138.1%	43.86%	-6.53%	25.61%	-12.16%
Enterprise Value (EV) ¹	1,073	2,318	3,109	2,761	3,411	2,902
Change	-	116.06%	34.11%	-11.2%	23.54%	-14.92%
P/E	8.32x	-175x	13.9x	24.8x	43.5x	56.5x
PBR	1.81x	4.41x	4.35x	3.49x	3.98x	3.3x
PEG	-	2x	-0x	-0.5x	-1.5x	-1.7x
Capitalization / Revenue	3.46x	11x	9.33x	7.36x	9.8x	8.1x
EV / Revenue	4.14x	12x	9.44x	7.08x	9.27x	7.42x
EV / EBITDA	11.9x	36.3x	17.4x	12.9x	19.8x	20.3x
EV / EBIT	26x	-3,050x	28.4x	19.5x	33.5x	39.4x
EV / FCF	-4.92x	-148x	26.6x	26x	71.4x	73.4x
FCF Yield	-20.3%	-0.68%	3.75%	3.84%	1.4%	1.36%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	1.766	-0.2	3.63	1.898	1.36	0.9197
Distribution rate	-	-	-	-	-	-
Net sales ¹	259.4	193.7	329.5	390.1	368.1	391
EBITDA ¹	89.8	63.8	179.2	213.6	172.6	143.2
EBIT ¹	41.3	-0.76	109.4	141.9	101.8	73.6
Net income ¹	107.8	-12.15	221.8	115.9	82.99	56.13
Net Debt ¹	175.7	182	35.85	-111.4	-196.9	-267
Reference price ²	14.70	35.00	50.35	47.06	59.11	51.92
Nbr of stocks (in thousands)	61,031	61,031	61,031	61,031	61,031	61,031
Announcement Date	9/2/20	9/2/21	8/30/22	9/5/23	9/2/24	9/1/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ZENOTECH LABORATORIES LIMITED	-	-	-	-	29.22M
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,109B
JOHNSON & JOHNSON	29.74x	-	-	2.01%	644B
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	463B
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	371B
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	301B
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	256B
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	234B
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	205B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.79x	6.73x	16.05x	2.34%	376.11B
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%